ARCHIVES

In Brief: Hew Approves Patent Request From U. Arizona; Califano Still Pondering Bioassay Program Fate

This article is from The Cancer Letter archive.

Vol. 04 No. 35 | September 1, 1978

Download PDF Visit The Full Archive

Related Articles

MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer.

March 2, 2001

Shorter Hospital Stay After Robot-Assisted Surgeries

February 27, 2009

Niederhuber says his job is easy, but times are hard: NCI may need to cut up to $150 million.

December 9, 2005

Rogers Eyes Saccharin Ban

March 18, 1977

Senate Passes Extension Ac; Kennedy Plans Saccharin Hearing

May 13, 1977

NCI-Approved Clinical Trials

January 27, 2006